The XJO is expected to edge lower on open this morning following another indecisive night of trading in the U.S on Friday which saw their market retake intraday losses to finish marginally lower. We should open near 7,320. Our next key level of support is at 7,280. At this stage it doesn’t seems like that
Read More
Every upcoming IPO company will provide a comprehensive Prospectus, typically spanning about 150 pages. While understanding the content of which you’re going to put money into matters the most, read more for some crucial information that could really help narrow down your search and make informed decisions during an IPO process! What is an IPO?
Read More
Australia’s housing market stands in the face of uncertainty. Heightened inflation, reduced supply and population growth has real estate investors, shareholders and citizens on the edge of their seats. Amid this, the property advertising firm REA Group (ASX: REA) observed a marginal 1% increase in revenue, reaching a total of $1.1 billion. There was a
Read More
New parents want nothing but the best for their kid, and baby product companies make sure to capitalise on that sentiment. Usually, no price tag can deter a new parent. But with the ongoing pressure on people’s household incomes, the tag becomes a sour spot, urging them to look for affordable ways to ensure their
Read More
The XJO is expected to open flat this morning following a tumultuous night of trading in the U.S which saw their market shed intraday gains to finish flat. However they still managed to hold key support and our market will likely take this as a positive sign. Don’t be surprised if we do see some
Read More
If you key in the word “stem cell” into a search engine, results will show they have the potential to treat most diseases (but don’t forget to look for clinically-proven sources!) There also exists an ASX-listed company focusing in stem cell therapeutics, aiming to be the panacea in treating the High-Risk acute Graft versus Host
Read More